Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ZimVie Inc. | 0 | déclaré | 20 oct. 2025 | tx 38+615 089−508 483 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 20 oct. 2025 | OTHER | ZimVie Inc. | 125 389 | — | |
| 20 oct. 2025 | OTHER | ZimVie Inc. | 227 851 | — | deriv |
| 01 oct. 2025 | TAX_WITHHOLDING | ZimVie Inc. | 1 057 | 18.93 USD | |
| 15 mai 2025 | TAX_WITHHOLDING | ZimVie Inc. | 3 927 | 8.73 USD | |
| 15 mai 2025 | EXERCISE | ZimVie Inc. | 16 127 | 0.00 USD | |
| 15 mai 2025 | EXERCISE | ZimVie Inc. | 16 127 | 0.00 USD | deriv |
| 10 mars 2025 | TAX_WITHHOLDING | ZimVie Inc. | 1 690 | 12.20 USD | |
| 10 mars 2025 | EXERCISE | ZimVie Inc. | 6 938 | 0.00 USD | |
| 07 mars 2025 | EXERCISE | ZimVie Inc. | 24 650 | 0.00 USD | |
| 07 mars 2025 | TAX_WITHHOLDING | ZimVie Inc. | 6 339 | 12.78 USD | |
| 10 mars 2025 | EXERCISE | ZimVie Inc. | 6 938 | 0.00 USD | deriv |
| 07 mars 2025 | EXERCISE | ZimVie Inc. | 24 650 | 0.00 USD | deriv |
| 04 mars 2025 | GRANT_AWARD | ZimVie Inc. | 114 047 | 0.00 USD | deriv |
| 01 oct. 2024 | TAX_WITHHOLDING | ZimVie Inc. | 1 058 | 15.70 USD | |
| 11 sept. 2024 | GRANT_AWARD | ZimVie Inc. | 48 380 | 0.00 USD | deriv |
| 15 mai 2024 | TAX_WITHHOLDING | ZimVie Inc. | 3 927 | 16.80 USD | |
| 15 mai 2024 | EXERCISE | ZimVie Inc. | 16 127 | 0.00 USD | |
| 15 mai 2024 | EXERCISE | ZimVie Inc. | 16 127 | 0.00 USD | deriv |
| 10 mars 2024 | EXERCISE | ZimVie Inc. | 6 939 | 0.00 USD | |
| 10 mars 2024 | TAX_WITHHOLDING | ZimVie Inc. | 1 690 | 17.86 USD | |
| 10 mars 2024 | EXERCISE | ZimVie Inc. | 6 939 | 0.00 USD | deriv |
| 07 mars 2024 | GRANT_AWARD | ZimVie Inc. | 73 948 | 0.00 USD | deriv |
| 28 déc. 2023 | TAX_WITHHOLDING | ZimVie Inc. | 11 366 | 18.25 USD | |
| 28 déc. 2023 | EXERCISE | ZimVie Inc. | 42 663 | 0.00 USD | |
| 28 déc. 2023 | EXERCISE | ZimVie Inc. | 42 663 | 0.00 USD | deriv |